ArticleJapanese journal of radiology2026
Deep learning reconstruction enhances 1.5T MR angiography beyond 3T in vascular visualization for Moyamoya disease.
Article in Japanese journal of radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeDeep learning reconstruction (DLR) is increasingly being applied to clinical magnetic resonance angiography (MRA); however, its evaluation across different magnetic field strengths in moyamoya disease is limited. This study assessed whether DLR affects visualization of stenotic arteries and collateral moyamoya vessels (MMVs). MATERIALS AND
methodsThirty-two patients (mean age, 40 years; male/female, 9/23) with suspected or confirmed moyamoya disease between 2015 and 2024 were retrospectively selected. All patients underwent time-of-flight MRA using 1.5T and 3T scanners within a 400-day interval. Differences in image quality and vascular visualization were assessed across four types of maximum intensity projection images from 1.5T and 3T MRA with and without DLR. The rankings of imaging quality and vascular depiction, Houkin classification scores, and visualization scores of the MMVs were compared using the Wilcoxon signed-rank test.
resultsWhen all four groups (1.5T and 3T MRA with/without DLR of 32 patients) were simultaneously compared using ranking scores, both overall image quality and visualization of MMVs were consistently rated higher for the DLR-enhanced images; notably, the 1.5T DLR-enhanced MRA achieved higher quality rankings than the 3T original MRA (p < 0.048). Houkin’s scores significantly decreased in DLR-enhanced MRA (p < 0.016) when compared at the same field strength, indicating less severe stenosis in DLR-enhanced images. MMVs visualization scores tended to shift toward higher grades after DLR, although this difference was not significant.
conclusionDLR significantly improved vascular visualization in moyamoya disease, with 1.5T DLR-enhanced MRA outperforming the original 3T MRA in terms of image quality and MMVs depiction.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.